Ambev (ABEV3) reported that its Board of Directors approved, at a meeting held on August 12 and 13, 2026, the cancellation of 279,000,000 common shares issued by the company and held in treasury, without a reduction in its capital stock. With the cancellation, the capital stock is now divided into 15,484,664,889 common shares.
According to the company, the amendment of the head provision of Article 5 of the Bylaws, to reflect the new number of shares, will be submitted to a General Meeting to be called in due course. The minutes of the Board of Directors meeting that approved the cancellation are available on the websites of the CVM, B3, and Ambev itself.
Ambev also reported that the share buyback program for its own shares, approved at a Board of Directors meeting held on October 29, 2025, was terminated due to reaching the limit of common shares for repurchase set forth in the program.
